Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link
Pharmacoepidemiology and Drug Safety · 2025-02 · 34 (2)
DOI: 10.1002/pds.5860 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 17.02.2025. Verfasst von Catherine Vasilakis-Scaramozza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA. Hauptthemen laut MEDLINE: Databases, Factual, Medical Record Linkage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: Amgen Inc, Amgen.
Abstract (Originalsprache)
Purpose
Assess the validity of the Clinical Practice Research Datalink (CPRD) Aurum Mother‐Baby Link (MBL).
Methods
We assessed the validity of CPRD Aurum MBL pairs using several strategies. Our study population was based on all available MBL pairs in a 100‐practice sample of CPRD Aurum. We sent a questionnaire to the general practitioner of a sample of MBL patients asking if linkage was correct and whether delivery date was correct within 14 days. We also compared MBL delivery date to the matched child's birth date in CPRD Aurum. Finally, in the Hospital Episode Statistics (HES) eligible population, we compared MBL delivery date to birthing parent's HES delivery date.
Results
The study population included 124 962 MBL pairs: 124 962 livebirths, 91 218 birthing parents, and 123 562 deliveries. Based on 361 questionnaire responses standardized to the MBL population, 85% (95% CI 74%–96%) of pairs were confirmed as correctly matched,
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Boston Collaborative Drug Surveillance Program, Lexington, Massachusetts, USA.
- Amgen Ltd, Uxbridge, UK.
- Boston University School of Public Health, Boston, Massachusetts, USA.
ORCID-Profile: Catherine Vasilakis-Scaramozza, Susan Jick
Förderung
- Amgen Inc
- Amgen
Zitieren
APA
Vasilakis-Scaramozza, C., Persson, R., Kafatos, G., Neasham, D., Hagberg, K. W., & Jick, S. (2025). Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link. Pharmacoepidemiology and Drug Safety, 34(2). https://doi.org/10.1002/pds.5860
Vancouver
Vasilakis-Scaramozza C, Persson R, Kafatos G, Neasham D, Hagberg KW, Jick S. Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link. Pharmacoepidemiology and Drug Safety. 2025;34(2). doi:10.1002/pds.5860
BibTeX
@article{VasilakisScaramozza2025,
author = {Vasilakis-Scaramozza, Catherine and Persson, Rebecca and Kafatos, George and Neasham, David and Hagberg, Katrina Wilcox and Jick, Susan},
title = {Validation of Clinical Practice Research Datalink ( CPRD ) Aurum Mother‐Baby Link},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2025},
volume = {34},
number = {2},
doi = {10.1002/pds.5860}
}
EUVIMED